Clinical Trial Update: Empagliflozin in Treatment of Peripheral Diabetic Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for empagliflozin in peripheral diabetic neuropathy across Phase 1 and Phase 2, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Tanta University | Conditions: Diabetic Neuropathy Peripheral | Phase 1, Phase 2 | Status: COMPLETED